Savara can be a medical-stage biopharmaceutical company establishing treatment plans for exceptional respiratory disorders. Its lead products candidate can be an immunostimulator called molgramostim. Molgramostim is in stage three clinical trials to treat autoimmune pulmonary alveolar proteinosis, or aPAP.I don’t have any magic tricks for complex